137 related articles for article (PubMed ID: 9308230)
1. Murine and human 3'IgH regulatory sequences.
Birshtein BK; Chen C; Saleque S; Michaelson JS; Singh M; Little RD
Curr Top Microbiol Immunol; 1997; 224():73-80. PubMed ID: 9308230
[No Abstract] [Full Text] [Related]
2. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors.
Klein G
Curr Top Microbiol Immunol; 1999; 246():161-7. PubMed ID: 10396052
[No Abstract] [Full Text] [Related]
4. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
Taub R; Kirsch I; Morton C; Lenoir G; Swan D; Tronick S; Aaronson S; Leder P
Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7837-41. PubMed ID: 6818551
[TBL] [Abstract][Full Text] [Related]
5. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors.
Klein G
Genes Chromosomes Cancer; 1989 Sep; 1(1):3-8. PubMed ID: 2487145
[No Abstract] [Full Text] [Related]
6. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
7. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
9. Myc oncogene activation in B and T lymphoid tumours.
Adams JM; Cory S
Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):59-72. PubMed ID: 2866524
[TBL] [Abstract][Full Text] [Related]
10. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
[TBL] [Abstract][Full Text] [Related]
11. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas.
Müller JR; Janz S; Potter M
Curr Top Microbiol Immunol; 1995; 194():425-9. PubMed ID: 7895518
[TBL] [Abstract][Full Text] [Related]
12. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.
Klein G
Cell; 1983 Feb; 32(2):311-5. PubMed ID: 6402307
[No Abstract] [Full Text] [Related]
13. Chromatin structural changes in the putative regulatory region of c-myc accompany the translocation in a Burkitt lymphoma.
Siebenlist U; Hennighausen L; Battey J; Leder P
Curr Top Microbiol Immunol; 1984; 113():183-9. PubMed ID: 6434235
[No Abstract] [Full Text] [Related]
14. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
Haluska FG; Tsujimoto Y; Croce CM
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
[TBL] [Abstract][Full Text] [Related]
15. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma.
Corcoran LM; Cory S; Adams JM
Cell; 1985 Jan; 40(1):71-9. PubMed ID: 2981633
[TBL] [Abstract][Full Text] [Related]
16. Forward and reverse changes in Ig/myc translocation carrying tumors.
Klein G
Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
18. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
[TBL] [Abstract][Full Text] [Related]
19. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma.
Rabbitts TH; Forster A; Baer R; Hamlyn PH
Nature; 1983 Dec 22-1984 Jan 4; 306(5945):806-9. PubMed ID: 6419124
[TBL] [Abstract][Full Text] [Related]
20. Recombination of the c-myc gene with IgH enhancer-S mu sequences in a murine plasmacytoma (DCPC21) without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Curr Top Microbiol Immunol; 1990; 166():267-78. PubMed ID: 2127395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
